Dissecting Gene Regulatory Roles of TET Enzymes and 5-hydroxymethylcytosine in Mammalian Active DNA Demethylation
Dissecting Gene Regulatory Roles of TET Enzymes and 5-hydroxymethylcytosine in Mammalian Active DNA Demethylation
批准号:
10251899
负责人:
Alex Tianjiun Wei
金额:
$4.6万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2023-05-31
关键词:
Base Excision RepairsBindingBiological ProcessCell LineageCell divisionCell physiologyCellsChromatinChromatin StructureClustered Regularly Interspaced Short Palindromic RepeatsComplexComprehensionCoupledCytosineDNADNA MethylationDNA Modification ProcessDNA biosynthesisDepositionDevelopmentDioxygenasesDiseaseES Cell LineEnzymesEpigenetic ProcessEtiologyExcision RepairExhibitsFamilyFoundationsGene ExpressionGene Expression RegulationGenerationsGenesGenetic TranscriptionGenetically Engineered MouseGenomic DNAHumanInheritedKineticsKnock-outKnockout MiceMammalian CellMammalsMeasuresMediatingMethodsMethylationMethyltransferaseMitoticModificationMusNatural regenerationNucleosomesOxidesPathologyPathway interactionsPhysiologic pulsePlayPositioning AttributeProcessProliferatingProtein translocationRegulator GenesRegulatory ElementResolutionRoleSamplingSomatic CellStructure of primordial sex cellSystemTechnologyTestingThymine DNA GlycosylaseTimeTranscriptional ActivationTranscriptional RegulationVariantWorkbasebisulfitebisulfite sequencingblastocystchromatin proteinchromatin remodelingdemethylationembryonic stem cellepigenome editingestablished cell lineexperimental studygenome-widegenome-wide analysishuman diseasein vivoinsightmammalian genomenovelnovel therapeuticsnucleobaseoverexpressionoxidationpluripotencypromoterrecruitrestorationtargeted treatmenttranscription factortumorigenesis
中文摘要
项目摘要
表观遗传修饰在细胞功能和细胞谱系的特化中具有重要作用。在DNA上,
表观遗传修饰发生在胞嘧啶核苷酸碱基的5位上。最常见的修改是5-
甲基胞嘧啶(5mC)和Tet-11转位(Tet)蛋白通过以下途径酶促DNA甲基化
将5mC反复氧化为5-羟甲基胞嘧啶(5hmC)、5-甲酰胞嘧啶(5fC)和5-羧基胞嘧啶
(5caC)。在哺乳动物中,Tet介导的活性DNA去甲基化可以通过复制依赖的稀释来实现
5hmC或胸腺嘧啶DNA糖基酶(TDG)介导的5fC/5caC碱基切除修复(BER)再生
然而,这些氧化修饰(OX-MC)的功能意义和力学意义
不同的活性DNA去甲基化途径仍然知之甚少,使我们无法理解
DNA甲基化异常导致疾病。事实上,OX-MC与关键的生物学作用有关
基因转录等过程。然而,将功能角色归因于OX-MC AS一直是一个挑战
将5hmC的产生与5fC/5caC和未修饰的C分离在技术上是具有挑战性的。
OX-MC的功能作用将为开发治疗多种疾病的新疗法奠定基础
病理学。为此,我开发了一个CRISPR/dCas9平台,它招募了5hmC-stating Tet-Variants来
探讨5hmC、5fC/5caC和TDG/BER在哺乳动物系统中的基因调控作用。
综合表观遗传测序(亚硫酸氢盐测序(BS-
SEQ)/亚硫酸盐辅助APOBEC偶联表观遗传测序(BACE-SEQ)/甲基酶辅助亚硫酸盐
测序(MAB-Seq)显示,5hmC单独不能重新激活高甲基化的基因启动子
增殖的人细胞,5fC/5caC的产生是必需的。这些结果首次表明,
OX-MC之间的功能差异。目前还不清楚下游更高的OX-MC通路如何
重新激活基因表达。I假设5fC/5CaC沉积耗尽核小体占有率
抄写。在目标1中,我将评估5hmC/5fC/5caC/C和TDG在Tet1-3三重敲除(TKO)中的作用和
Tet1-3/TDG四基因敲除小鼠胚胎干细胞对基因表达和局部表达的影响
染色质结构。我的结果还表明,仅靠5hmC不能通过依赖复制恢复未修改的C
稀释5hmC表明这种活性DNA去甲基化的机制比
之前已经预料到了。对OX-MC碱基如何跨有丝分裂遗传的全基因组定量分析
目前缺乏部门。我假设5hmC是有丝分裂遗传给新生的链,而5fC/5caC是
由TDG/BER快速去除。在目标2中,我将开发技术来量化和描述ox-MC有丝分裂
遗传工程mESCs中单碱基分辨率的遗传。
通过完成提议的目标,我将对活跃的dna去甲基化提供前所未有的洞察力。
OX-MC的通路和功能作用将有助于我们理解疾病的发生。
英文摘要
Project Summary
Epigenetic modifications have important roles in cellular functions and in specialization of cell lineages. On DNA,
epigenetic modification occurs on the 5-position of cytosine nucleobases. The most common modification is 5-
methylcytosine (5mC), and TET-Eleven-Translocation (TET) proteins enzymatically remove DNA methylation by
iteratively oxidizing 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxycytosine
(5caC). In mammals, TET-mediated active DNA demethylation can be achieved by replication-dependent dilution
of 5hmC, or thymine DNA glycosylase (TDG) mediated base excision repair (BER) of 5fC/5caC to regenerate
unmodified C. However, the functional significance of these oxidized modifications (ox-mC) and mechanistically
distinct active DNA demethylation pathways remains poorly understood, precluding our comprehension on how
dysregulated DNA methylation contributes to disease. Indeed, ox-mC has been implicated in crucial biological
processes such as gene transcription. However, it has been challenging to ascribe functional roles to ox-mC as
it was technically challenging to decouple generation of 5hmC from 5fC/5caC, and unmodified C. Elucidating
functional roles of ox-mC will establish a foundational understanding for developing novel therapeutics for various
pathologies. To this end, I developed a CRISPR/dCas9 platform that recruits 5hmC-stalling TET-variants to
interrogate gene regulatory roles of 5hmC, 5fC/5caC, and TDG/BER in mammalian systems.
Preliminary results generated from comprehensive epigenetic sequencing (bisulfite sequencing (BS-
Seq)/Bisulfite-assisted APOBEC-Coupled Epigenetic sequencing (bACE-Seq)/Methylase-Assisted Bisulfite
sequencing (MAB-Seq)) revealed 5hmC alone could not reactivate a hypermethylated gene promoter in
proliferative human cells, and generation of 5fC/5caC was requisite. These results show for the first time,
functional distinction between ox-mC. It remains ambiguous how downstream higher ox-mC pathways could
reactivate gene expression. I hypothesize 5fC/5caC deposition depletes nucleosome occupancy to facilitate
transcription. In aim 1, I will evaluate the role of 5hmC/5fC/5caC/C and TDG in Tet1-3 triple knock out (TKO) and
Tet1-3/Tdg quadruple knockout (QKO) mouse embryonic stem cells (mESCs), on gene expression and local
chromatin structure. My results also reveal 5hmC alone could not restore unmodified C by replication-dependent
dilution of 5hmC suggesting this mechanism of active DNA demethylation is more tightly regulated than
previously anticipated. Quantitative genome-wide analysis of how ox-mC bases is mitotically inherited across
division is currently lacking. I hypothesize 5hmC is mitotically inherited to nascent strands, while 5fC/5caC is
rapidly removed by TDG/BER. In aim 2, I will develop technologies to quantify and profile ox-mC mitotic
inheritance at single-base resolution in genetically engineered mESCs.
By completing the proposed aims, I will afford unprecedented insight into active DNA demethylation
pathways and functional roles of ox-mC that will contribute to our understanding of disease inception.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting Gene Regulatory Roles of TET Enzymes and 5-hydroxymethylcytosine in Mammalian Active DNA Demethylation
-
批准号:10413217
-
项目类别:
-
资助金额:$2.62万
-
财政年份:2020
-
负责人:Alex Tianjiun Wei
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: